Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Niu Y et al. | Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy. | 2011 | Prostate | pmid:21308715 |
Kang HJ et al. | The first successful paternity through in vitro fertilization-intracytoplasmic sperm injection with a man homozygous for the 5α-reductase-2 gene mutation. | 2011 | Fertil. Steril. | pmid:21334614 |
Guardiola-Serrano F et al. | Palmitoylation of human FasL modulates its cell death-inducing function. | 2010 | Cell Death Dis | pmid:21368861 |
Jusakul A et al. | Mechanisms of oxysterol-induced carcinogenesis. | 2011 | Lipids Health Dis | pmid:21388551 |
Graupp M et al. | Association of genetic variants in the two isoforms of 5α-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome. | 2011 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:21530059 |
Askarova S et al. | Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to aβ Peptide-induced membrane changes. | 2011 | Int J Alzheimers Dis | pmid:21547213 |
Nicholson TM and Ricke WA | Androgens and estrogens in benign prostatic hyperplasia: past, present and future. | 2011 Nov-Dec | Differentiation | pmid:21620560 |
Aggarwal S et al. | QSAR studies on human 5alpha-reductase inhibitors: unsaturated 3-carboxysteroids. | 2011 May-Jun | Acta Pol Pharm | pmid:21648201 |
Baudrand R et al. | Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. | 2011 | Metab. Clin. Exp. | pmid:21704348 |
Mohler JL et al. | Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone. | 2011 | Clin. Cancer Res. | pmid:21705451 |